AXIKIN PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 21234
 
  
 
C07D HETEROCYCLIC COMPOUNDS 16146
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 491
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 3135
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 367
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9730914 3,5-diaminopyrazole kinase inhibitorsNov 29, 16Aug 15, 17[A61K]
9637460 Isotopically enriched arylsulfonamide CCR3 antagonistsJul 13, 15May 02, 17[A61K, C07D, C07B]
9546163 3,5-diaminopyrazole kinase inhibitorsDec 22, 15Jan 17, 17[A61K, C07D, C12N]
9540351 Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitorsSep 17, 14Jan 10, 17[A61K, C07D, C07C]
9382237 3,5-diaminopyrazole kinase inhibitorsNov 24, 14Jul 05, 16[A61K, C07F, C07D]
9365556 3,5-diaminopyrazole kinase inhibitorsMar 14, 13Jun 14, 16[A61K, C07F, C07D]
9346792 3,5-diaminopyrazole kinase inhibitorsDec 17, 14May 24, 16[A61K, C07F, C07D]
9206186 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disordersAug 26, 13Dec 08, 15[A61K, C07D, C07C]
9187425 2,5-disubstituted arylsulfonamide CCR3 antagonistsAug 30, 13Nov 17, 15[A61K, A01N, C07D]
9156799 Isotopically enriched arylsulfonamide CCR3 antagonistsSep 06, 13Oct 13, 15[A61K, C07D, C07B]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0079,954 PHARMACEUTICALLY ACCEPTABLE SALTS OF 3,5-DIAMINOPYRAZOLE KINASE INHIBITORSAbandonedNov 30, 16Mar 23, 17[A61K]
2016/0031,841 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTSAbandonedOct 12, 15Feb 04, 16[A61K, C07D]
2014/0221,428 ARYLSULFONAMIDE CCR3 ANTAGONISTSAbandonedApr 22, 14Aug 07, 14[A61K, C07D]
8669247 2,5-disubstituted arylsulfonamide CCR3 antagonistsExpiredMar 18, 13Mar 11, 14[A61K]
8563544 2,5-disubstituted arylsulfonamide CCR3 antagonistsExpiredOct 26, 12Oct 22, 13[A61K, C07D]
8420639 Arylsulfonamide CCR3 antagonistsExpiredApr 21, 10Apr 16, 13[A61K, C07D]
8399456 2,5-disubstituted arylsulfonamide CCR3 antagonistsExpiredApr 21, 10Mar 19, 13[A61K, C07D]
2012/0088,769 SALTS OF ARYLSULFONAMIDE CCR3 ANTAGONISTSAbandonedOct 10, 11Apr 12, 12[A61K, C07D, A61P]
2006/0240,424 Regulation of human p2y15 g protein-coupled receptorAbandonedSep 25, 03Oct 26, 06[C12Q, C12N, G01N]
2006/0052,329 Regulation of human P2Y1-like G protein-coupled receptorAbandonedSep 09, 05Mar 09, 06[A61K, C07H, C12P, C07K]
2005/0148,014 Regulation of human P2Y1-like G protein-coupled receptorAbandonedFeb 23, 05Jul 07, 05[C07H, A61K, C12Q, C07K]
2004/0076,985 Regulation of human chemokine-like receptorAbandonedOct 27, 03Apr 22, 04[C07H, C12Q, G01N, C07K]
2004/0038,879 Regulation of human p2y1-like g protein-coupled receptorAbandonedFeb 14, 03Feb 26, 04[A61K, C12P, C12N, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.